secwatch.observer — SEC 8-K summary
======================================

Issuer:     Humacyte, Inc. (HUMA)
CIK:        0001818382
Form:       8-K
Filed at:   2024-10-07T23:59:59+00:00
Accession:  0001104659-24-106404
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Humacyte prices $30M registered direct offering of common stock and warrants at $5.28/unit
--------------------------------------------------------------------------------

- Offering of 5,681,820 common shares and 5,681,820 warrants at $5.28 per unit.
- Gross proceeds approximately $30M before fees and expenses.
- Warrants split: 2,840,910 expire in 6 months; 2,840,910 expire in 4.5 years; exercise price $5.28 each.
- Expected to close October 7, 2024; EF Hutton acting as placement agent with 6% fee plus expense cap.
- Offered under effective shelf registration statement on Form S-3 (File No. 333-267225).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818382/000110465924106404/0001104659-24-106404-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818382/000110465924106404/tm2425697d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-106404

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer